---
schema_version: "secwatch.filing_event.v1"
accession: "0001299130-24-000198"
form_type: "8-K/A"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2024-12-13T23:59:59+00:00"
generated_at: "2026-05-29T03:22:01.933103+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pacific Biosciences discloses CCO Jeff Eidel's separation terms: $485K severance, 12-month COBRA

## Summary
- Jeff Eidel's employment as CCO ended Nov 15, 2024; separation agreement signed Dec 6, effective Dec 13.
- Eidel receives lump sum of $485,000 (12 months base salary) and up to 12 months COBRA premium payments.
- Vested stock options must be exercised within 3 months of separation or forfeited; unvested RSUs/PSUs cancelled.
- Eidel agrees to release all claims, maintain confidentiality, and refrain from disparagement.
- Company will instruct executive officers and board to refrain from disparaging Eidel.

## SEC filing metadata
- accession: 0001299130-24-000198
- form_type: 8-K/A
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2024-12-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000129913024000198/0001299130-24-000198-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000129913024000198/pacb-20241111.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001299130-24-000198
- JSON: https://secwatch.observer/filing/0001299130-24-000198.json
- Plain text: https://secwatch.observer/filing/0001299130-24-000198.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.